Role of inducible nitric oxide synthase pathway on methotrexate-induced intestinal mucositis in rodents

BMC Gastroenterology

Volumn 11, Issue , 2011, Pages

  Leitão, Renata F C ^a   Brito, Gerly A C ^a   Oriá, Reinaldo B ^a   Braga Neto, Manuel B ^a   Bellaguarda, Emmanuelle A L ^a   Silva, Johann V ^a   Gomes, Antoniella S ^a   Lima Júnior, Roberto C P ^a   Siqueira, Francisco J W S ^a   Freire, Rosemeyre S ^a   Vale, Mariana L ^a   Ribeiro, Ronaldo A ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

Aminoguanidine; Methotrexate; N Nitro L arginine methyl ester; Nitric oxide; Nitric oxide synthase

Indexed keywords

3 NITROTYROSINE; AMINOGUANIDINE; INDUCIBLE NITRIC OXIDE SYNTHASE; KI 67 ANTIGEN; METHOTREXATE; MYELOPEROXIDASE; N(G) NITROARGININE METHYL ESTER; 3-NITROTYROSINE; DRUG DERIVATIVE; ENZYME INHIBITOR; GUANIDINE DERIVATIVE; NITRIC OXIDE; PEROXIDASE; TYROSINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; ENTERITIS; ENZYME ACTIVITY; ENZYME ASSAY; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSITIS; INTESTINE CRYPT; INTESTINE VILLUS; JEJUNUM; MALE; MOUSE; MUCOSA INFLAMMATION; NEUTROPHIL; NICK END LABELING; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; RAT; RODENT; SIGNAL TRANSDUCTION; SMALL INTESTINE; TISSUE SECTION; WILD TYPE; WISTAR RAT; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; METABOLISM; MOUSE MUTANT; PHYSIOLOGY;

ANIMALS; CELL DEATH; CELL PROLIFERATION; ENZYME INHIBITORS; GUANIDINES; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; INJECTIONS, INTRAPERITONEAL; KI-67 ANTIGEN; MALE; METHOTREXATE; MICE; MICE, KNOCKOUT; MUCOSITIS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PEROXIDASE; RATS; RATS, WISTAR; TYROSINE;

EID: 80051644417     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-11-90     Document Type: Article

References (46)

1. Duncan M, Grant G. Review article: oral and intestinal mucositis - causes and possible treatments. Aliment Pharmacol Ther 2003, 18:853-874. 10.1046/j.1365-2036.2003.01784.x, 14616150.
2. Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M, Bekele BN, Raber-Durlacher J, Donnelly JP, Rubenstein EB. Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 2004, 100(9):1995-2025. Review, 10.1002/cncr.20162, 15108222.
3. Koning BA, Sluis M, Lindenbergh-Kortleve DJ, Velcich A, Pieters R, Buller HA, Einerhand AW, Renes IB. Methotrexate-induced mucositis in mucin 2-deficient mice. J Cell Physiol 2007, 210(1):144-152. 10.1002/jcp.20822, 16998802.
4. Margolis S, Philips FS, Sternberg SS. The cytotoxicity of methotrexate in mouse small intestine in relation to inhibition of folic acid reductase and of DNA synthesis. Cancer Res 1971, 31(12):2037-2046.
5. Carneiro-Filho BA, Lima IP, Cavalcante MC, Carvalho GH, Brito GA, Lima V, Monteiro SM, Santos FN, Ribeiro RA, Lima AA. Intestinal barrier function and secretion in methotrexate-induced rat intestinal mucositis. Dig Dis Sci 2004, 49(1):65-72.
6. Paris F, Fuks Z, Kang A, et al. Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science 2001, 293:293-297. 10.1126/science.1060191, 11452123.
7. Sonis ST, Peterson RL, Edwards LJ, et al. Defining mechanisms of action of interleukin-11 on the progression of radiation-induced oral mucositis in hamsters. Oral Oncol 2000, 36:373-381. 10.1016/S1368-8375(00)00012-9, 10899677.
8. Logan RM, Stringer AM, Bowen JM, Yeoh AS, Gibson RJ, Sonis ST, Keefe DM. The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: pathobiology, animal models and cytotoxic drugs. Cancer Treat Rev 2007, 33(5):448-460. 10.1016/j.ctrv.2007.03.001, 17507164.
9. Liew FY. Nitric oxide and asthmatic inflammation. Immunol Today 1995, 16:128-130. 10.1016/0167-5699(95)80128-6, 7536418.
10. Liew FY. Nitric oxide in infectious and autoimmune diseases. Ciba Found Symp 1995, 195:234-239. discussion 2392-2344. Review.
11. Moilanen E, Vapaatalo H. Nitric oxide in inflammation and immune response. Ann Med 1995, 27(3):359-67. Review, 10.3109/07853899509002589, 7546626.
12. Bruch-Gerharz D, Ruzicka T, Kolb-Bachofen V. Nitric oxide in human skin: current status and future prospects. J Invest Dermatol 1998, 110(1):1-7. 10.1046/j.1523-1747.1998.00084.x, 9424078.
13. Moncada S, Palmer RMJ, Hibbs JR, Higgs AE. Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev 1991, 43:109-142.
14. Griffiths MJD, Messent M, Mac Allister RJ, Evans TW. Aminoguanidine selectively inhibits inducible nitric oxide synthase. Br J Pharmacol 1993, 110(3):963-968. 2175814, 7507781.
15. Ribeiro RA, Bellaguarda EA, Macedo FD, Silva LR, Oria RB, Vale ML, Cunha FQ, Brito GA. Role of nitric oxide on pathogenesis of 5-fluorouracil induced experimental oral mucositis in hámster. Cancer Chemother Pharmacol 2007, 59(5):603-12. 10.1007/s00280-006-0301-y, 16944152.
16. Muscará MN, Wallace JL, Nitric Oxide V. therapeutic potential of nitric oxide donors and inhibitors. Am J Physiol 1999, 276(6):1313-1316. Review.
17. Gow AJ, Duran D, Malcolm S, Ischiropoulos H. Effects of peroxynitrite-induced protein modifications on tyrosine phosphorylation and degradation. FEBS Lett 1996, 385(1-2):63-66. 10.1016/0014-5793(96)00347-X, 8641468.
18. Kolli VK, Abraham P, Rabi S. Methotrexate-induced nitrosative stress may play a critical role in small intestinal damage in the rat. Arch Toxicol 2008, 82(10):763-70. 10.1007/s00204-008-0287-9, 18253714.
19. Park JHY, Mohammadpour H, Blackwood D. Effects of dietary lipids on recorvery from mucosal injury. Gastroenterology 1990, 98:1226-1231.
20. Macpherson BR, Pfeiffer CJ. Experimental production of diffuse colitis in rats. Digestion 1978, 17:35-50.
21. Soares PM, Mota JM, Gomes AS, Oliveira RB, Assreuy AM, Santos AA, Ribeiro RA, Souza MH. Gastrointestinal dysmotility in 5-fluorouracil-induced intestinal mucositis outlasts inflammatory process resolution. Cancer Chemother Pharmacol 2008, 63(1):91-98. 10.1007/s00280-008-0715-9, 18324404.
22. Souza MH, Troncon LE, Cunha FQ, Oliveira RB. Decreased gastric tone and delayed gastric emptying precede neutrophil infiltration and mucosal lesion formation in indomethacin-induced gastric damage in rats. Braz J Med Biol Res 2003, 36(10):1383-1390. 10.1590/S0100-879X2003001000015, 14502371.
23. Gerdes J, Li L, Schlueter C, Duchrow M, Wohlenberg C, Gerlach C, Stahmer I, Kloth S, Brandt E, Flad FD. Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 1991, 138(4):867-73. 1886092, 2012175.
24. Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol 2000, 182(3):311-22. 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9, 10653597.
25. Hsu SM, Raine L. Protein A, avidin, and biotin in immunohistochemistry. J Histochem Cytochem 1981, 29(11):1349-1353. 10.1177/29.11.6172466, 6172466.
26. Estrada C, Gomez C, Martin C, Moncada S, Gonzalez C. Nitric oxide mediates tumor necrosis factor-alpha cytotoxicity in endothelial cells. Biochem Biophys Res Commun 1992, 186(1):475-482. 10.1016/S0006-291X(05)80832-0, 1378728.
27. Ralston SH, Todd D, Helfrich MH, Benjamin N, Grabowski P. Human osteoblast-like cells produce nitric oxide and express inducible nitric oxide synthase. Endocrinology 1994, 135:330-336. 10.1210/en.135.1.330, 7516867.
28. Hall PD, Benko H, Hogan KR, Stuart RK. The influence of serum tumor necrosis factor-alpha and interleukin-6 concentrations on nonhematologic toxicity and hematologic recovery in patients with acute myelogenous leukemia. Exp Hematol 1995, 23(12):1256-1260.
29. Koning BA, Van Dieren JM, Lindenbergh-Kortleve DJ, Van der Sluis M, Matsumoto T, Einerhand AW, Samsom JN, Pieters R, Nieuwenhuis EE. Contributions of mucosal immune cells to methotrexate-induced mucositis. Int Immunol 2006, 18(6):941-949. 10.1093/intimm/dxl030, 16636014.
30. Potoka DA, Nadler ED, Upperman JS, Ford HR. Role of nitric oxide and peroxynitrite in gut barrier failure. World J Surg 2002, 26(7):806-811. 10.1007/s00268-002-4056-2, 11948371.
31. Seo HG, Tanaka I, Nakamura M, Tatsumi H, Suzuki K, Fujii J, Taniguchi N. Induction of nitric oxide synthase and concomitant suppression of superoxide dismutases in experimental colitis in rats. Arch Biochem Biophys 1995, 324(1):41-47. 10.1006/abbi.1995.9932, 7503557.
32. Miller MJ, Sadowska-Krowicka H, Chotinaruemol S, Kakkis JL, Clark DA. Amelioration of chronic ileitis by nitric oxide synthase inhibition. J Pharmacol Exp Ther 1993, 264(1):11-16.
33. Kubes P, Suzuki M, Granger DN. Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci 1991, 88:4651-4655. 10.1073/pnas.88.11.4651, 51723, 1675786.
34. Peng HB, Spiecker M, Liao JK. Inducible nitric oxide: An autoregulatory feedback inhibitor of vascular inflammation. J Immunol 1998, 161:1970-1976.
35. Martin SW, Stevens AJ, Brennan BS, Davies D, Rowland M, Houston JB. The six-day-old rat air pouch model of inflammation: Characterization of the inflammatory response to carrageenan. J Pharmacolog Toxicolog Meth 1994, 32:139-147.
36. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and ugly. Am J Physiol 1996, 271:1424-1437.
37. Kong SK, Yim MB, Stadtman ER, Chock PB. Peroxynitrite disables the tyrosine phosphorylation regulatory mechanism: Lymphocyte-specific tyrosine kinase fails to phosphorylate nitrated cdc2(6-20)NH2 peptide. Proc Natl Acad Sci 1996, 93(8):3377-3382. 10.1073/pnas.93.8.3377, 39616, 8622943.
38. Radi R, Beckman JS, Bush KM, Freeman BA. Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys 1991, 288(2):481-487. 10.1016/0003-9861(91)90224-7, 1654835.
39. Radi R, Beckman JS, Bush KM, Freeman BA. Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J Biol Chem 1991, 266(7):4244-4250.
40. Potoka DA, Upperman JS, Zhang XR, Kaplan JR, Corey SJ, Grishin A, Zamora R, Ford HR. Peroxynitrite inhibits enterocyte proliferation and modulates Src kinase activity in vitro. Am J Physiol Gastrointest Liver Physiol 2003, 285(5):86186-86189.
41. Battinelli E, Loscalzo J. Nitric oxide induces apoptosis in megakaryocytic cell lines. Blood 2000, 95(11):3451-3459.
42. Estevez AG, Jordan J. Nitric oxide and superoxide, a deadly cocktail. Ann N Y Acad Sci 2002, 962:207-211. Review, 10.1111/j.1749-6632.2002.tb04069.x, 12076976.
43. Sandoval M, Liu X, Mannick EE, Clark DA, Miller J. Peroxynitrite-induced apoptosis in human intestinal epithelial cells is attenuated by mesalamine. Gastroenterology 1997, 113(5):1480-1488. 10.1053/gast.1997.v113.pm9352850, 9352850.
44. Nakamura H, Tsukada H, Oya M, Onomura M, Saito T, Fukuda K, Kodama M, Taniguchi T, Tominaga M, Hosokawa M, Seino Y. Aminoguanidine has both an anti-inflammatory effect on experimental colitis and a proliferative effect on colonic mucosal cells. Scand J Gastroenterol 1999, 34(11):1117-22. 10.1080/003655299750024922, 10582763.
45. Chokshi NK, Guner YS, Hunter CJ, Upperman JS, Grishin A, Ford HR. The role of nitric oxide in intestinal epithelial injury and restitution inneonatal necrotizing enterocolitis. Semin Perinatol 2008, 32(2):92-99. 10.1053/j.semperi.2008.01.002, 2390779, 18346532.
46. Kawamori T, Takahashi M, Watanabe K, Ohta T, Nakatsugi S, Sugimura T, Wakabayashi K. Suppression of azoxymethane-induced colonic aberrant crypt foci by a nitric oxide synthase inhibitor. Cancer Lett 2000, 148(1):33-37. 10.1016/S0304-3835(99)00310-9, 10680590.